To build scope & capacity for clinical research
New evidence based knowledge
Research into effective clinical practice
- About Us
- Contact Us
For free and confidential advice about alcohol and other drugs, call the National Alcohol and Other Drug hotline: 1800 250 015. It will automatically direct you to the Alcohol and Drug Information Service in your state or territory. Click here for more information
An online text-based counselling for people concerned about their own drinking or drug use. The service is equally available to people concerned about a family member, relative or friend. Click here for more information
The National Centre for Clinical Research on Emerging Drugs (NCCRED) commissioned the National Centre for Education and Training on Addiction (NCETA) to review Australian methamphetamine-related clinical guidelines.
Twenty-seven methamphetamine-related clinical guidelines were identified, some of which solely addressed methamphetamine (or stimulants) specifically, while others were generic but had component parts of relevance.
A purpose-built framework to map each guideline according to treatment setting and target population, and modified version of the Appraisal of Guidelines for Research and Evaluation (AGREE) instrument were developed by NCETA to assess the guidelines for concordance with contemporary standards for clinical guidelines.
The audit found that most guidelines were useful resources with valuable clinical utility that serve the needs of a wide range of treatment settings and population groups, nevertheless there were gaps and limitations in the current guidelines.
Such gaps include:
This examination of methamphetamine-related clinical guidelines is intended to support the National Ice Action Strategy by identifying gaps in resources to support the AOD workforce, how these gaps could be addressed and where further research may be required to support future guideline development.
The full report is available here: